OraSure Technologies
Update in progressOSUR (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Instruments & Supplies
OraSure Technologies and subsidiaries develop, manufacture, market and sell diagnostic tests and specimen collection devices worldwide. Products include OraQuick HIV, HIV self-test, HCV, Syphilis and Ebola rapid tests, InteliSwab COVID tests, SickleSCAN, oral-fluid collection devices, Intercept drug testing, Oragene/ORAcollect genetic kits, Colli-Pee and HEMAcollect, and OMNIgene microbiome and saliva collection systems. Founded 1987, Bethlehem, PA.
Company score
- Sentiment
- 0.49
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.60
- Governance
- 0.13
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.21
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.35
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEOMs. Carrie Eglinton Manner
- Founded1987
- Employees500
- Websitewww.orasure.com
Identifiers
- ISINUS68554V1089
- FIGIBBG000J3D1Y8
- LEI529900GNNJPNM4XHXQ77
- CUSIP68554V108
- CIK0001116463